BROOKS vs ERIS: Stock Comparison
ERIS LIFESCIENCES is the larger company by market capitalisation. BROOKS LAB shows a lower P/E, a higher ROE and lower leverage, while ERIS LIFESCIENCES shows a higher dividend yield, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BROOKS leads 5; ERIS leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BROOKS | ERIS |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | BROOKS | ERIS |
|---|---|---|
| Live Price | ₹63.02 | ₹1,168.2 |
| Day Change | -1.28% | 0.4% |
| Volume | 26,399 | 7,112 |
| 52-Week High | ₹116 | ₹1,740 |
| 52-Week Low | ₹36.3 | ₹1,069 |
| Distance from 52W High | -45.67% | -32.86% |
Valuation
| Metric | BROOKS | ERIS |
|---|---|---|
| Market Cap | ₹190 Cr | ₹16,242 Cr |
| P/E Ratio | 8.22x | 22.71x |
| P/B Ratio | 1.65x | 3.88x |
| EPS | ₹4.49 | ₹51.42 |
| Book Value | ₹41.64 | ₹281.69 |
| Dividend Yield | 0% | 1.2% |
Growth
| Metric | BROOKS | ERIS |
|---|---|---|
| Revenue Growth (TTM YoY) | -6.37% | 7.1% |
| EPS Growth (TTM YoY) | 0% | 200% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | BROOKS | ERIS |
|---|---|---|
| ROE | 20.04% | 7.64% |
| ROCE | 5.38% | 10.32% |
| Net Margin | 28.67% | 19.89% |
| Operating Margin | 7.74% | 29.73% |
| Debt to Equity | 0.06x | 0.65x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | BROOKS | ERIS |
|---|---|---|
| Promoter Holding | 52.62% | 54.74%▲ 0.6 pp |
| FII Holding | 0.04%▲ 0.04 pp | 5.74%▼ 0.01 pp |
| DII Holding | 10.5%▲ 0.12 pp | 20.2%▼ 0.52 pp |
| Public Holding | 36.84%▼ 0.16 pp | 19.32%▼ 0.08 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BROOKS LAB and ERIS LIFESCIENCES.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.